Zhitong Finance App News, Keji Pharmaceutical-B (02171.HK) announced that the preliminary results of CT0596 (an allogeneic CAR-T cell candidate product targeting BCMA) were reported at the 67th American Society of Hematology (ASH) Annual Meeting.

Zhitongcaijing · 2d ago
Zhitong Finance App News, Keji Pharmaceutical-B (02171.HK) announced that the preliminary results of CT0596 (an allogeneic CAR-T cell candidate product targeting BCMA) were reported at the 67th American Society of Hematology (ASH) Annual Meeting.